Rens de Groot

1.2k total citations
33 papers, 850 citations indexed

About

Rens de Groot is a scholar working on Hematology, Immunology and Cancer Research. According to data from OpenAlex, Rens de Groot has authored 33 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Rens de Groot's work include Complement system in diseases (14 papers), Platelet Disorders and Treatments (11 papers) and Protease and Inhibitor Mechanisms (8 papers). Rens de Groot is often cited by papers focused on Complement system in diseases (14 papers), Platelet Disorders and Treatments (11 papers) and Protease and Inhibitor Mechanisms (8 papers). Rens de Groot collaborates with scholars based in United Kingdom, Belgium and United States. Rens de Groot's co-authors include James T. B. Crawley, David A. Lane, Yaozu Xiang, Salvatore Santamaria, Brenda M. Luken, Marie Scully, Mari Thomas, Ajoy Bardhan, Karen Vanhoorelbeke and Alain Colige and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rens de Groot

28 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rens de Groot United Kingdom	15	464	422	186	124	124	33	850
Elaine M. Majerus United States	13	1.1k 2.5×	954 2.3×	462 2.5×	207 1.7×	93 0.8×	24	1.6k
Gabriel M. Romo United States	12	242 0.5×	605 1.4×	91 0.5×	207 1.7×	36 0.3×	13	980
Monica Schaller Switzerland	15	498 1.1×	116 0.3×	116 0.6×	249 2.0×	39 0.3×	28	880
Bojing Shao United States	14	406 0.9×	230 0.5×	55 0.3×	271 2.2×	77 0.6×	29	945
Kirsten Neubert Germany	10	483 1.0×	230 0.5×	102 0.5×	414 3.3×	35 0.3×	13	1.0k
Viktoria Rumjantseva United States	7	141 0.3×	441 1.0×	49 0.3×	233 1.9×	47 0.4×	9	805
Laure Croisille France	15	251 0.5×	530 1.3×	218 1.2×	335 2.7×	42 0.3×	33	1.0k
Janet Chou United States	5	178 0.4×	629 1.5×	127 0.7×	351 2.8×	103 0.8×	5	1.1k
Gerrie Stoeken‐Rijsbergen Netherlands	16	342 0.7×	96 0.2×	109 0.6×	118 1.0×	58 0.5×	20	903

Countries citing papers authored by Rens de Groot

Since Specialization

Citations

This map shows the geographic impact of Rens de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rens de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rens de Groot more than expected).

Fields of papers citing papers by Rens de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rens de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rens de Groot. The network helps show where Rens de Groot may publish in the future.

Co-authorship network of co-authors of Rens de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Rens de Groot. A scholar is included among the top collaborators of Rens de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rens de Groot. Rens de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Daniel R., Roberta Moschini, Antonella Del Corso, et al.. (2025). Characterization of ADAMTS9 proteoglycanase activity: Comparison with ADAMTS1, ADAMTS4, and ADAMTS5. Journal of Biological Chemistry. 301(7). 110301–110301.

Vanhoorelbeke, Karen, et al.. (2025). A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission. Journal of Thrombosis and Haemostasis. 23(10). 3185–3197.

Cuffaro, Doretta, Xiaohan Zhang, Tiziano Tuccinardi, et al.. (2024). Design, synthesis and biological evaluation of arylsulfonamides as ADAMTS7 inhibitors. RSC Medicinal Chemistry. 15(8). 2806–2825.

Thomas, Mari, Rens de Groot, Andrew J. Doyle, et al.. (2023). Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia. Journal of Thrombosis and Haemostasis. 22(2). 455–465. 2 indexed citations

Scully, Marie, et al.. (2023). P1612: CALPROTECTIN LEVELS ARE ELEVATED IN CONGENITAL TTP AND IMMUNE TTP AT ADAMTS13 RELAPSE. HemaSphere. 7(S3). e2092072–e2092072. 1 indexed citations

Groot, Rens de, Melissa Heightman, Toby Hillman, et al.. (2023). Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. Journal of Thrombosis and Haemostasis. 21(1). 94–100. 14 indexed citations

Singh, Deepak, et al.. (2023). ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura. Research and Practice in Thrombosis and Haemostasis. 7(2). 100108–100108. 18 indexed citations

Zhang, Xiaohan, et al.. (2023). N-Glycan Insertion for Probing Protein–Protein Interactions and Epitope Mapping. Methods in molecular biology. 2747. 41–53. 1 indexed citations

Santamaria, Salvatore, Elisa Nuti, Doretta Cuffaro, et al.. (2021). Development of a fluorogenic ADAMTS-7 substrate. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 2160–2169. 4 indexed citations

10.

Santamaria, Salvatore, Doretta Cuffaro, Elisa Nuti, et al.. (2021). Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide. Scientific Reports. 11(1). 949–949. 19 indexed citations

11.

Santamaria, Salvatore & Rens de Groot. (2020). ADAMTS proteases in cardiovascular physiology and disease. Open Biology. 10(12). 200333–200333. 48 indexed citations

12.

Groot, Rens de. (2019). ADAMTS7: Recombinant Protein Expression and Purification. Methods in molecular biology. 2043. 63–73. 5 indexed citations

13.

Santamaria, Salvatore, Kazuhiro Yamamoto, Christopher D. Koch, et al.. (2019). Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis. Scientific Reports. 9(1). 10914–10914. 28 indexed citations

14.

Kim, Hyo Jung, Rens de Groot, Chan Li, et al.. (2019). Crystal structure and substrate-induced activation of ADAMTS13. Nature Communications. 10(1). 3781–3781. 62 indexed citations

15.

Colige, Alain, et al.. (2019). Proteomic discovery of substrates of the cardiovascular protease ADAMTS7. Journal of Biological Chemistry. 294(20). 8037–8045. 40 indexed citations

16.

Thomas, Mari, Rens de Groot, Marie Scully, & James T. B. Crawley. (2015). Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. EBioMedicine. 2(8). 942–952. 91 indexed citations

17.

Crawley, James T. B., Rens de Groot, Yaozu Xiang, Brenda M. Luken, & David A. Lane. (2011). Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 118(12). 3212–3221. 214 indexed citations

18.

Kornelisse, René F., Marcel Sluijter, Lodewijk Spanjaard, Peter W. M. Hermans, & Rens de Groot. (1996). Molecular epidemiological characteristics of pneumococcal meningitis in children. European Journal of Clinical Microbiology & Infectious Diseases. 15(8). 635–638. 5 indexed citations

19.

Jonkers, G. J. P. M., et al.. (1994). Acute thyroiditis caused by Moraxella nonliquefaciens.. PubMed. 45(4). 170–3. 5 indexed citations

20.

Neijens, Herman J., M. Sinaasappel, Rens de Groot, J.C. de Jongste, & Shelley E. Overbeek. (1990). Cystic fibrosis, pathophysiological and clinical aspects. European Journal of Pediatrics. 149(11). 742–751. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact